The healthcare sector in the United States is at a critical juncture as private equity (PE) firms tighten their grip on hospitals, igniting fierce debate over the consequences for patient care and raising serious concerns about the balance between profit and well-being. With over $1 trillion
In a world still grappling with the aftermath of a global health crisis that recorded over 700 million cases and 7 million deaths, the role of COVID-19 vaccines stands as a testament to human ingenuity and scientific progress. These vaccines, developed at an unprecedented pace through years of
In a world where cancer continues to challenge medical science, recent advancements offer a glimmer of hope for millions of patients grappling with this complex disease, and each year, countless individuals face diagnoses that turn their lives upside down. The urgency to develop effective,
Imagine reaching for a refreshing soda on a hot day, unaware that this simple choice might play a role in accelerating a deadly disease, as recent research has spotlighted a troubling link between sugary drinks and the spread of colorectal cancer to the liver, a leading cause of mortality among
Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, and a deep understanding of technological innovation in the industry. Ivan has been closely involved in groundbreaking studies that are shaping the future of
Imagine a world where treatments for complex diseases are tailored to an individual’s unique genetic makeup, offering hope to patients who have long been out of options, and Alnylam Pharmaceuticals, a pioneer in RNA interference (RNAi) therapeutics, is turning this vision into reality by joining
